Capital Flow Monitor · Sponsors · CIK 1280776
IMMUNIC, INC.
1200 AVENUE OF THE AMERICAS, NEW YORK, X1, 10036 · (332) 255-9818
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$200.0M
Sold
$200.0M
% sold
100.0%
Investors
43
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | D ·current | 506(b) | $200.0M | $200.0M | 100.0% | 43 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- DANIEL VITT — Executive Officer / Director, New York, NY
- SIMONA SKERJANEC — Director, NEW YORK, NY
- DUANE NASH — Director, New York, NY
- TAMAR HOWSON — Director, New York, NY
- JOERG NEERMAN — Director, New York, NY
- RICHARD RUDICK — Director, New York, NY
- ANDREAS MUEHLER — Executive Officer, New York, NY
- PATRICK WALSH — Executive Officer, New York, NY
- THORVALD NAGEL — Director, New York, NY
- HELLA KOHLHOF — Executive Officer, New York, NY
- GLENN WHALEY — Executive Officer, New York, NY
- INDERPAL SINGH — Executive Officer, New York, NY
- BARCLAY PHILLIPS — Director, New York, NY
- JASON TARDIO — Executive Officer, New York, NY
Placement agents
- Stifel, Nicolaus & Company Incorporated · 35 RE raises
- Guggenheim Securities, Llc · 0 RE raises
- Leerink Partners Llc · 0 RE raises
- Lifesci Capital Llc · 0 RE raises
- William Blair & Company, Llc · 0 RE raises
- B. Riley Securities, Inc. · 0 RE raises
- Brookline Capital Markets, A Division Of Arcadia Securities, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.